Cosmos Health Stockholders Elect Directors, Approve Series B Preferred Stock

Cosmos Health Inc. held its 2026 Annual Meeting of Stockholders on July 15, 2026, where all proposals were approved. Stockholders elected six directors to the Board and authorized the issuance and designation of 100,000 shares of Series B Preferred Stock. Additionally, the 2026 Equity Omnibus Plan was approved, and the appointment of the independent registered public accounting firm was ratified. Approximately 47% of the company's outstanding shares were represented at the meeting.